Literature DB >> 35034567

Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Nevins W Todd1,2, Sergei P Atamas1,2, Stella E Hines1, Irina G Luzina1,2, Nirav G Shah1, Edward J Britt1, Andrew J Ghio3, Jeffrey R Galvin1,4.   

Abstract

INTRODUCTION: A major focus of interstitial lung disease (ILD) has centered on disorders termed idiopathic interstitial pneumonias (IIPs) which include, among others, idiopathic pulmonary fibrosis, idiopathic nonspecific interstitial pneumonia, cryptogenic organizing pneumonia, and respiratory bronchiolitis-interstitial lung disease. AREAS COVERED: We review the radiologic and histologic patterns for the nine disorders classified by multidisciplinary approach as IIP, and describe the remarkable amount of published epidemiologic, translational, and molecular studies demonstrating their associations with numerous yet definitive environmental exposures, occupational exposures, pulmonary diseases, systemic diseases, medication toxicities, and genetic variants. EXPERT OPINION: In the 21st century, these disorders termed IIPs are rarely idiopathic, but rather are well-described radiologic and histologic patterns of lung injury that are associated with a wide array of diverse etiologies. Accordingly, the idiopathic nomenclature is misleading and confusing, and may also promote a lack of inquisitiveness, suggesting the end rather than the beginning of a thorough diagnostic process to identify ILD etiology and initiate patient-centered management. A shift toward more etiology-focused nomenclature will be beneficial to all, including patients hoping for better life quality and disease outcome, general medicine and pulmonary physicians furthering their ILD knowledge, and expert ILD clinicians and researchers who are advancing the ILD field.

Entities:  

Keywords:  Idiopathic interstitial pneumonia; idiopathic pulmonary fibrosis; interstitial lung disease; nonspecific interstitial pneumonia; organizing pneumonia; usual interstitial pneumonia

Mesh:

Year:  2022        PMID: 35034567      PMCID: PMC8983480          DOI: 10.1080/17476348.2022.2030710

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  157 in total

Review 1.  Immune thrombocytopenia: no longer 'idiopathic'.

Authors:  Keith McCrae
Journal:  Cleve Clin J Med       Date:  2011-06       Impact factor: 2.321

2.  Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia.

Authors:  A A Liebow; C B Carrington
Journal:  Med Clin North Am       Date:  1973-05       Impact factor: 5.456

3.  Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact.

Authors:  Martina Bonifazi; Nicola Sverzellati; Eva Negri; Joseph Jacob; Ryoko Egashira; Joanna Moser; Sara Piciucchi; Federico Mei; Angelo De Lauretis; Dina Visca; Nicole Goh; Matteo Bonini; Laura Cirilli; Carlo La Vecchia; Felix Chua; Vasileios Kouranos; George Margaritopoulos; Maria Kokosi; Toby M Maher; Stefano Gasparini; Armando Gabrielli; Athol U Wells; Elisabetta A Renzoni
Journal:  Eur Respir J       Date:  2020-07-09       Impact factor: 16.671

4.  Clinical features of pulmonary aspergillosis associated with interstitial pneumonia.

Authors:  Fumio Kurosaki; Masashi Bando; Masayuki Nakayama; Naoko Mato; Takakiyo Nakaya; Hideaki Yamasawa; Taichiro Yoshimoto; Noriyoshi Fukushima; Yukihiko Sugiyama
Journal:  Intern Med       Date:  2014-06-15       Impact factor: 1.271

5.  Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect.

Authors:  Andrew J Ghio; Elizabeth D Hilborn; Jacqueline G Stonehuerner; Lisa A Dailey; Jacqueline D Carter; Judy H Richards; Kay M Crissman; Robert F Foronjy; Dale L Uyeminami; Kent E Pinkerton
Journal:  Am J Respir Crit Care Med       Date:  2008-08-21       Impact factor: 21.405

6.  Pleuroparenchymal Fibroelastosis: Its Clinical Characteristics.

Authors:  Kentaro Watanabe
Journal:  Curr Respir Med Rev       Date:  2013-06

7.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Sebastian Majewski; Wojciech Piotrowski
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

8.  Idiopathic pulmonary fibrosis and GERD: links and risks.

Authors:  Matteo Ghisa; Carla Marinelli; Vincenzo Savarino; Edoardo Savarino
Journal:  Ther Clin Risk Manag       Date:  2019-09-05       Impact factor: 2.423

Review 9.  The Role of Infection in Interstitial Lung Diseases: A Review.

Authors:  Natalya Azadeh; Andrew H Limper; Eva M Carmona; Jay H Ryu
Journal:  Chest       Date:  2017-04-08       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.